Hydroxyapatite/biodegradable poly(L-lactide-co-ε-caprolactone) composite microparticles as injectable scaffolds by a Pickering emulsion route.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 20807593.
- Also identified by DOI 10.1016/j.actbio.2010.08.023.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hydroxyapatite (HAp)/biodegradable poly(L-lactide-co-ε-caprolactone) (P(LA/CL)) composite microparticles were fabricated as an injectable scaffold via the Pickering emulsion route in the absence of any molecular surfactants. A stable oil in water emulsion was obtained using water dispersed HAp nanocrystals as the particulate emulsifier and a dichloromethane (CH(2)Cl(2)) solution of P(LA/CL) as the oil phase. The concentration-viscosity relationship of the P(LA/CL) solution and its influence on the formation of a stable emulsion were investigated. The dependence of homogenization on the concentration of the P(LA/CL) solution and shear speed of homogenization was also evaluated. HAp/P(LA/CL) microparticles of various morphologies, such as plates and spheres, or with various surface morphologies were realized through adjustment of the concentration and composition of the P(LA/CL) solution. The microparticles were observed by optical microscopy and scanning electronic microscopy and their size distributions measured using a microparticle size analyzer. The weight percentages of HAp nanocrystals on the HAp/P(LA/CL) microparticles of different average sizes were measured by thermogravimetric analysis.
Medical subject headings
- Biocompatible Materials
- Durapatite
- Materials Testing
- Nanoparticles
- Polyesters
- Tissue Scaffolds